https://doi.org/10.4081/hmr.v2i13.502

Chemotherapy in cutaneous T-cell lymphoma

Vol. 2 No. 13: It’s time to take care of T-Cell Lymphomas Bologna, Italy, 22-24 October 2006
Published: June 10, 2009
Abstract Views: 172
PDF: 373
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

S Rupoli
support@pagepress.org
MG Bernengo
R Alterini
M Cantonetti
PL Zinzani
N Pimpinelli
Which and when aggressive treatment in cutaneous T-cell lymphoma (CTCL)? When approaching the topic of chemotherapy in different subtypes of CTCL,1 the first issue to be made clear is the target of this type of treatment. The use of systemic chemotherapy as a first line treatment should be restricted with few exceptions to advanced/aggressive forms of CTCL: advanced mycosis fungoides (MF, stage IIB-IV), Sézary syndrome (SS), primary cutaneous CD30+ anaplastic large cell lymphoma with disseminated lesions, subcutaneous panniculitis-like T-cell lymphoma with progressive lesions, and peripheral T-cell lymphoma, unspecified.

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite

Rupoli, S., Bernengo, M., Alterini, R., Cantonetti, M., Zinzani, P., & Pimpinelli, N. (2009). Chemotherapy in cutaneous T-cell lymphoma. Hematology Meeting Reports (formerly Haematologica Reports), 2(13). https://doi.org/10.4081/hmr.v2i13.502
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).